Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myopic Choroidal Neovascularization”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableNot Yet RecruitingNCT07009574
What this trial is testing

The Treatment Burden of Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularisationAnti-VEGF TreatmentBurden
Policlinico Gaspare Rodolico - San Marco Catania 100
Large-scale testing (Phase 3)Study completedNCT00370786
What this trial is testing

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Who this might be right for
Choroidal Neovascularization
Shahid Beheshti University of Medical Sciences 31
Early research (Phase 1)Temporarily pausedNCT04222842
What this trial is testing

CM082 in Patients With Myopic Choroidal Neovascularization (CNV)

Who this might be right for
Myopic Choroidal Neovascularisation
AnewPharma 96
Not applicableStudy completedNCT04524910
What this trial is testing

Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)

Who this might be right for
Myopic Choroidal Neovascularization
Bayer 28
Large-scale testing (Phase 3)Study completedNCT01922102
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
Novartis Pharmaceuticals 457
Not applicableWithdrawnNCT01218230
What this trial is testing

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

Who this might be right for
Myopic Choroidal Neovascular Membrane
L.V. Prasad Eye Institute
Very early researchNot Yet RecruitingNCT06879301
What this trial is testing

Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients

Who this might be right for
Diabetic Macular Edema (DME)Retinal Vein Occlusion (RVO)Myopic Choroidal Neovascularisation
Tanta University 60
Early research (Phase 1)Study completedNCT00407719
What this trial is testing

Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationDegenerative MyopiaPathological Myopia
Johns Hopkins University 10
Not applicableStudy completedNCT02175940
What this trial is testing

VEGF and PEDF in Patients With Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularizationVEGF Aqueous LevelPEDF Aqueous Level
Università degli Studi di Brescia 40
Not applicableStudy completedNCT03963596
What this trial is testing

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 122
Not applicableActive Not RecruitingNCT06527274
What this trial is testing

Effect of Defocus in Soft Contact Lenses on Internal Retinal Vascularization

Who this might be right for
Nearsightedness
Université de Montréal 25
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Not applicableStudy completedNCT02260687
What this trial is testing

Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Bayer 353
Early research (Phase 1)Study completedNCT01968486
What this trial is testing

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Who this might be right for
Myopia, Degenerative
University of Campania Luigi Vanvitelli 60
Not applicableNot Yet RecruitingNCT06357559
What this trial is testing

OCTA Changes in Choroidal Neovascularization in High Myopia

Who this might be right for
Myopic Choroidal Neovascularisation
Sohag University 100
Large-scale testing (Phase 3)Study completedNCT01217944
What this trial is testing

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Pathological Myopia
Novartis Pharmaceuticals 277
Not applicableNot Yet RecruitingNCT07402629
What this trial is testing

Deep Learning-Based OCTA Quantification and Modeling for Predicting Long-Term Anti-VEGF Efficacy in mCNV

Who this might be right for
Myopic Choroidal Neovascularization
Second Affiliated Hospital, School of Medicine, Zhejiang University 110
Large-scale testing (Phase 3)Active Not RecruitingNCT06176352
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Choroidal Neovascularization Secondary to Pathologic Myopia
Hoffmann-La Roche 280
Not applicableStudy completedNCT05677685
What this trial is testing

VISUPRIME® Eye Drops

Who this might be right for
Macular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic Retinopathy+2 more
VISUfarma SpA 78
Post-approval studies (Phase 4)UnknownNCT02033018
What this trial is testing

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

Who this might be right for
Choroidal Retinal Neovascularization
Instituto de Olhos de Goiania 20
Load More Results